1. Home
  2. PDSB
  3. PDSB News

Latest PDS Biotechnology Corporation (PDSB) News on November 17, 2025

PDS Biotechnology Corp (PDSB) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ...
PDSB

GuruFocus.com

3 days ago

PDS Biotechnology Corp (PDSB) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ...

PDSB

Associated Press Finance

3 days ago

PDS Biotechnology: Q3 Earnings Snapshot

PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
PDSB

GlobeNewswire

3 days ago

PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update

PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
PDSB

GlobeNewswire

5 days ago

PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering

PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
PDSB

GlobeNewswire

6 days ago

PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025

PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
PDSB

GlobeNewswire

10 days ago

PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results

New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting
PDSB

GlobeNewswire

18 days ago

New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting

PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer
PDSB

GlobeNewswire

18 days ago

PDS Biotech to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer

PDS Biotech to Host Key Opinion Leader Event to Discuss Versamune® HPV for the Treatment of HPV16+ HNSCC
PDSB

GlobeNewswire

5 months ago

PDS Biotech to Host Key Opinion Leader Event to Discuss Versamune® HPV for the Treatment of HPV16+ HNSCC

PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
PDSB

GlobeNewswire

5 months ago

PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

PDS Biotechnology Corporation (PDSB)’s Versamune HPV Surpasses Survival Benchmarks in Recurrent Head and Neck Cancer Trial
PDSB

Insider Monkey

6 months ago

PDS Biotechnology Corporation (PDSB)’s Versamune HPV Surpasses Survival Benchmarks in Recurrent Head and Neck Cancer Trial

PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
PDSB

GlobeNewswire

6 months ago

PDS Biotech Announces Positive Extended Follow-Up Data for VERSATILE-002 and Additional Trials Evaluating Versamune® HPV to be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

PDS Biotech to Participate at the A.G.P. Virtual Annual Healthcare Company Showcase
PDSB

GlobeNewswire

6 months ago

PDS Biotech to Participate at the A.G.P. Virtual Annual Healthcare Company Showcase

PDS Biotechnology Corp (PDSB) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...
PDSB

GuruFocus.com

6 months ago

PDS Biotechnology Corp (PDSB) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ...

PDSB

Thomson Reuters StreetEvents

6 months ago

Q1 2025 PDS Biotechnology Corp Earnings Call

PDSB

Associated Press Finance

6 months ago

PDS Biotechnology: Q1 Earnings Snapshot

PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update
PDSB

GlobeNewswire

6 months ago

PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PDSB

GlobeNewswire

6 months ago

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting
PDSB

GlobeNewswire

6 months ago

PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting

PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results
PDSB

GlobeNewswire

6 months ago

PDS Biotech Announces Conference Call and Webcast for First Quarter 2025 Financial Results

PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
PDSB

GlobeNewswire

7 months ago

PDS Biotech Announces Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting
PDSB

GlobeNewswire

7 months ago

PDS Biotech Announces Preclinical Influenza Data to be Presented in Symposium at IMMUNOLOGY2025™ Annual Meeting

PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
PDSB

GlobeNewswire

7 months ago

PDS Biotech Announces PDS01ADC Clinical Data to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
PDSB

GuruFocus.com

8 months ago

PDS Biotechnology Corp (PDSB) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

PDSB

Thomson Reuters StreetEvents

8 months ago

Q4 2024 PDS Biotechnology Corp Earnings Call

PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update
PDSB

GlobeNewswire

8 months ago

PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update

PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference
PDSB

GlobeNewswire

8 months ago

PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference

PDS Biotechnology (PDSB): Among the Penny Stocks With Huge Upside Potential According to Analysts
PDSB

Insider Monkey

8 months ago

PDS Biotechnology (PDSB): Among the Penny Stocks With Huge Upside Potential According to Analysts

PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results
PDSB

GlobeNewswire

8 months ago

PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing
PDSB

GlobeNewswire

8 months ago

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

PDSB

MT Newswires

8 months ago

PDS Biotechnology Receives FDA Clearance for Versamune MUC1 Trial in Colon Cancer

PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer
PDSB

GlobeNewswire

8 months ago

PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer

Life Sciences Investor Forum Agenda Announced for March 13th
PDSB

GlobeNewswire

8 months ago

Life Sciences Investor Forum Agenda Announced for March 13th

PDS Biotech Leadership to Participate in March Conferences
PDSB

GlobeNewswire

8 months ago

PDS Biotech Leadership to Participate in March Conferences

PDS Biotechnology commences trial for head and neck squamous cell carcinoma
PDSB

Clinical Trials Arena

8 months ago

PDS Biotechnology commences trial for head and neck squamous cell carcinoma

PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer
PDSB

GlobeNewswire

8 months ago

PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer

PDSB

MT Newswires

9 months ago

PDS Biotechnology Launches Registered Direct Offering; Shares Up

PDS Biotech Announces up to $22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PDSB

GlobeNewswire

9 months ago

PDS Biotech Announces up to $22 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA Oncology
PDSB

GlobeNewswire

9 months ago

PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA Oncology

PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research
PDSB

GlobeNewswire

9 months ago

PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research

PDS Biotech to Participate at B. Riley Securities Precision Oncology & Radiopharma Conference 2025
PDSB

GlobeNewswire

9 months ago

PDS Biotech to Participate at B. Riley Securities Precision Oncology & Radiopharma Conference 2025

PDS Biotech Reaffirms Guidance for First Quarter Initiation of VERSATILE-003 Phase 3 Clinical Trial in HPV16-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
PDSB

GlobeNewswire

9 months ago

PDS Biotech Reaffirms Guidance for First Quarter Initiation of VERSATILE-003 Phase 3 Clinical Trial in HPV16-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PDSB

GlobeNewswire

a year ago

PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET
PDSB

GlobeNewswire

a year ago

PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET

PDSB

MT Newswires

a year ago

B. Riley Cuts Price Target on PDS Biotechnology to $7 From $9, Keeps Buy Rating

Down -35.74% in 4 Weeks, Here's Why PDS Biotechnology (PDSB) Looks Ripe for a Turnaround
PDSB

Zacks

a year ago

Down -35.74% in 4 Weeks, Here's Why PDS Biotechnology (PDSB) Looks Ripe for a Turnaround

PDS Biotechnology Corp (PDSB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
PDSB

GuruFocus.com

a year ago

PDS Biotechnology Corp (PDSB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...

PDSB

Associated Press Finance

a year ago

PDS Biotechnology: Q3 Earnings Snapshot

PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results
PDSB

GlobeNewswire

a year ago

PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results

PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time
PDSB

GlobeNewswire

a year ago

PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time

PDS Biotechnology (PDSB) Upgraded to Strong Buy: Here's What You Should Know
PDSB

Zacks

a year ago

PDS Biotechnology (PDSB) Upgraded to Strong Buy: Here's What You Should Know

PDS Biotech Announces Presentation of Rationale and Design of First Recurrent Prostate Cancer Trial to Combine an Androgen Receptor Pathway Inhibitor with an Immunocytokine
PDSB

GlobeNewswire

a year ago

PDS Biotech Announces Presentation of Rationale and Design of First Recurrent Prostate Cancer Trial to Combine an Androgen Receptor Pathway Inhibitor with an Immunocytokine

Best Momentum Stocks to Buy for October 15th
PDSB

Zacks

a year ago

Best Momentum Stocks to Buy for October 15th

PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune® HPV and Chemoradiation
PDSB

GlobeNewswire

a year ago

PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune® HPV and Chemoradiation

PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024
PDSB

GlobeNewswire

a year ago

PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024

PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024
PDSB

GlobeNewswire

a year ago

PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024

PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
PDSB

GlobeNewswire

a year ago

PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference

PDSB

Associated Press Finance

a year ago

PDS Biotechnology: Q2 Earnings Snapshot

PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
PDSB

GlobeNewswire

a year ago

PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results

PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting
PDSB

GlobeNewswire

a year ago

PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting

PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024
PDSB

GlobeNewswire

a year ago

PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024

PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer
PDSB

GlobeNewswire

a year ago

PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer

PDS Biotech to Host Clinical Program Update Conference Call on August 1, 2024, at 8 a.m. Eastern Time
PDSB

GlobeNewswire

a year ago

PDS Biotech to Host Clinical Program Update Conference Call on August 1, 2024, at 8 a.m. Eastern Time

PDS Biotech to Participate at BTIG Virtual Biotechnology Conference
PDSB

GlobeNewswire

a year ago

PDS Biotech to Participate at BTIG Virtual Biotechnology Conference

PDSB

MT Newswires

a year ago

B. Riley Lowers Price Target on PDS Biotechnology to $9 From $11, Maintains Buy Rating

PDS Biotech Provides Data Update from Ongoing VERSATILE-002 Phase 2 Clinical Trial in Head and Neck Cancer
PDSB

GlobeNewswire

a year ago

PDS Biotech Provides Data Update from Ongoing VERSATILE-002 Phase 2 Clinical Trial in Head and Neck Cancer

PDSB

Associated Press Finance

2 years ago

PDS Biotechnology: Q1 Earnings Snapshot

PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
PDSB

GlobeNewswire

2 years ago

PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results

PDSB

MT Newswires

2 years ago

PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study

PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
PDSB

GlobeNewswire

2 years ago

PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer

PDS Biotech to Participate in Upcoming May 2024 Investor Conferences
PDSB

GlobeNewswire

2 years ago

PDS Biotech to Participate in Upcoming May 2024 Investor Conferences

PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024
PDSB

GlobeNewswire

2 years ago

PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024

PDS Biotechnology Announces Details of Virtual KOL Event
PDSB

GlobeNewswire

2 years ago

PDS Biotechnology Announces Details of Virtual KOL Event

PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
PDSB

GlobeNewswire

2 years ago

PDS Biotech Appoints Stephan Toutain as Chief Operating Officer

PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
PDSB

GlobeNewswire

2 years ago

PDS Biotech to Host Key Opinion Leader Event to Discuss Positive, Updated Data from Phase 2 VERSATILE-002 Clinical Trial with Versamune® HPV in Combination with KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer

PDS Biotechnology Corporation's (NASDAQ:PDSB) market cap dropped US$1.5m last week; individual investors who hold 59% were hit as were institutions
PDSB

Simply Wall St.

2 years ago

PDS Biotechnology Corporation's (NASDAQ:PDSB) market cap dropped US$1.5m last week; individual investors who hold 59% were hit as were institutions

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript
PDSB

Insider Monkey

2 years ago

PDS Biotechnology Corporation (NASDAQ:PDSB) Q4 2023 Earnings Call Transcript

PDSB

Thomson Reuters StreetEvents

2 years ago

Q4 2023 PDS Biotechnology Corp Earnings Call

PDSB

GuruFocus.com

2 years ago

PDS Biotechnology Corp (PDSB) Reports Full Year 2023 Financial Results and Clinical Strategy Update

PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
PDSB

GlobeNewswire

2 years ago

PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results

PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results
PDSB

GlobeNewswire

2 years ago

PDS Biotechnology Announces Conference Call and Webcast for Business Update and Full Year 2023 Financial Results

PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®
PDSB

GlobeNewswire

2 years ago

PDS Biotech Announces Publication of Preclinical Research and Grant of U.S. Composition of Matter Patent for Infectimune®

Dakota Gold Discovers Rare Earth Mineralization up to 12.9% over 4.9 Feet in New TD Zone at the Richmond Hill Gold Project
PDSB

Newsfile

2 years ago

Dakota Gold Discovers Rare Earth Mineralization up to 12.9% over 4.9 Feet in New TD Zone at the Richmond Hill Gold Project

DMC Global Announces Strategic Alternatives Process for DynaEnergetics and NobelClad Businesses
PDSB

GlobeNewswire

2 years ago

DMC Global Announces Strategic Alternatives Process for DynaEnergetics and NobelClad Businesses

Chuck Royce Reduces Stake in NVE Corp
PDSB

GuruFocus.com

2 years ago

Chuck Royce Reduces Stake in NVE Corp

Virco Manufacturing Corporation (VIRC) Is a Great Choice for 'Trend' Investors, Here's Why
PDSB

Zacks

2 years ago

Virco Manufacturing Corporation (VIRC) Is a Great Choice for 'Trend' Investors, Here's Why

PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer
PDSB

GlobeNewswire

2 years ago

PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer

CarParts.com Announces Extension of $30 Million Repurchase Plan
PDSB

PR Newswire

2 years ago

CarParts.com Announces Extension of $30 Million Repurchase Plan

PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference
PDSB

GlobeNewswire

2 years ago

PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference

Is Now The Time To Look At Buying Tile Shop Holdings, Inc. (NASDAQ:TTSH)?
PDSB

Simply Wall St.

2 years ago

Is Now The Time To Look At Buying Tile Shop Holdings, Inc. (NASDAQ:TTSH)?

Endeavour Silver Produces 5,672,703 Oz Silver and 37,858 Oz Gold (8.7 Million Silver Equivalent Oz) in 2023; Improved Fourth Quarter Production Delivers Annual Guidance
PDSB

GlobeNewswire

2 years ago

Endeavour Silver Produces 5,672,703 Oz Silver and 37,858 Oz Gold (8.7 Million Silver Equivalent Oz) in 2023; Improved Fourth Quarter Production Delivers Annual Guidance

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PDSB

Business Wire

2 years ago

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Is DLH Holdings Corp. (DLHC) Stock Priced for the “Worst Case” Scenario?
PDSB

Insider Monkey

2 years ago

Is DLH Holdings Corp. (DLHC) Stock Priced for the “Worst Case” Scenario?

Capital Allocation Trends At TrueBlue (NYSE:TBI) Aren't Ideal
PDSB

Simply Wall St.

2 years ago

Capital Allocation Trends At TrueBlue (NYSE:TBI) Aren't Ideal

Natural Grocers® Now Hiring for New Store in Incline Village, NV
PDSB

PR Newswire

2 years ago

Natural Grocers® Now Hiring for New Store in Incline Village, NV

Visa (V) Enhances Customer Experience With New Loyalty Solution
PDSB

Zacks

2 years ago

Visa (V) Enhances Customer Experience With New Loyalty Solution

Amprius Successfully Completes First Volume Shipment of Safe Cells for the U.S. Army
PDSB

Business Wire

2 years ago

Amprius Successfully Completes First Volume Shipment of Safe Cells for the U.S. Army

PDSB

Business Wire

2 years ago

Angel Oak Financial Strategies Income Term Trust Declares January 2024 Distribution

All You Need to Know About PDS Biotechnology (PDSB) Rating Upgrade to Buy
PDSB

Zacks

2 years ago

All You Need to Know About PDS Biotechnology (PDSB) Rating Upgrade to Buy

With 77% ownership, Priority Technology Holdings, Inc. (NASDAQ:PRTH) insiders have a lot at stake
PDSB

Simply Wall St.

2 years ago

With 77% ownership, Priority Technology Holdings, Inc. (NASDAQ:PRTH) insiders have a lot at stake

Share on Social Networks: